These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23477614)

  • 1. Markers of cell division cycle in glioblastoma: significance in prediction of treatment response and patient prognosis.
    Yousaf J; Hills C; Dixit S; Achawal S; O'Brien D; Greenman J; Scott IS
    Br J Neurosurg; 2013 Dec; 27(6):752-8. PubMed ID: 23477614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minichromosome maintenance-7 and geminin are reliable prognostic markers in patients with oral squamous cell carcinoma: immunohistochemical study.
    Tamura T; Shomori K; Haruki T; Nosaka K; Hamamoto Y; Shiomi T; Ryoke K; Ito H
    J Oral Pathol Med; 2010 Apr; 39(4):328-34. PubMed ID: 20136698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical estimation of cell cycle entry and phase distribution in astrocytomas: applications in diagnostic neuropathology.
    Scott IS; Morris LS; Rushbrook SM; Bird K; Vowler SL; Burnet NG; Coleman N
    Neuropathol Appl Neurobiol; 2005 Oct; 31(5):455-66. PubMed ID: 16150117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression.
    Gonzalez MA; Tachibana KE; Chin SF; Callagy G; Madine MA; Vowler SL; Pinder SE; Laskey RA; Coleman N
    J Pathol; 2004 Oct; 204(2):121-30. PubMed ID: 15376260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel immunohistochemical method to estimate cell-cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer.
    Scott IS; Morris LS; Bird K; Davies RJ; Vowler SL; Rushbrook SM; Marshall AE; Laskey RA; Miller R; Arends MJ; Coleman N
    J Pathol; 2003 Oct; 201(2):187-97. PubMed ID: 14517835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of proliferation markers Ki67, cyclin A, geminin and aurora-kinase A in primary breast carcinomas and corresponding distant metastases.
    Tökés AM; Szász AM; Geszti F; Lukács LV; Kenessey I; Turányi E; Meggyesházi N; Molnár IA; Fillinger J; Soltész I; Bálint K; Hanzély Z; Arató G; Szendröi M; Kulka J
    J Clin Pathol; 2015 Apr; 68(4):274-82. PubMed ID: 25595275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA replication licensing and cell cycle kinetics of oligodendroglial tumours.
    Wharton SB; Hibberd S; Eward KL; Crimmins D; Jellinek DA; Levy D; Stoeber K; Williams GH
    Br J Cancer; 2004 Jul; 91(2):262-9. PubMed ID: 15199392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential utility of geminin as a predictive biomarker in breast cancer.
    Sundara Rajan S; Hanby AM; Horgan K; Thygesen HH; Speirs V
    Breast Cancer Res Treat; 2014 Jan; 143(1):91-8. PubMed ID: 24292956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.
    Dudderidge TJ; Stoeber K; Loddo M; Atkinson G; Fanshawe T; Griffiths DF; Williams GH
    Clin Cancer Res; 2005 Apr; 11(7):2510-7. PubMed ID: 15814627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
    Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
    J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geminin, Ki67, and minichromosome maintenance 2 in gastric hyperplastic polyps, adenomas, and intestinal-type carcinomas: pathobiological significance.
    Shomori K; Nishihara K; Tamura T; Tatebe S; Horie Y; Nosaka K; Haruki T; Hamamoto Y; Shiomi T; Nakabayashi M; Ito H
    Gastric Cancer; 2010 Aug; 13(3):177-85. PubMed ID: 20820987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer.
    Gonzalez MA; Pinder SE; Callagy G; Vowler SL; Morris LS; Bird K; Bell JA; Laskey RA; Coleman N
    J Clin Oncol; 2003 Dec; 21(23):4306-13. PubMed ID: 14645419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological findings and prognostic factors in recurrent glioblastomas.
    Okita Y; Narita Y; Miyakita Y; Ohno M; Fukushima S; Kayama T; Shibui S
    Brain Tumor Pathol; 2012 Oct; 29(4):192-200. PubMed ID: 22331317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis.
    May M; Burger M; Otto W; Hakenberg OW; Wieland WF; May D; Hofstädter F; Götz S; Niessl N; Fritsche HM; Birnkammer K; Gilfrich C; Peter J; Jain A; Koch S; Lebentrau S; Riedmiller H; Rössler W; Denzinger S; Brookman-May S; Gunia S
    BJU Int; 2013 Aug; 112(4):E383-90. PubMed ID: 23305250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA replication licensing and cell cycle kinetics of normal and neoplastic breast.
    Shetty A; Loddo M; Fanshawe T; Prevost AT; Sainsbury R; Williams GH; Stoeber K
    Br J Cancer; 2005 Nov; 93(11):1295-300. PubMed ID: 16278669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value.
    Joshi S; Watkins J; Gazinska P; Brown JP; Gillett CE; Grigoriadis A; Pinder SE
    BMC Cancer; 2015 Jul; 15():546. PubMed ID: 26205655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical estimation of cell cycle phase in laryngeal neoplasia.
    Chatrath P; Scott IS; Morris LS; Davies RJ; Bird K; Vowler SL; Coleman N
    Br J Cancer; 2006 Aug; 95(3):314-21. PubMed ID: 16832409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting recurrence after oral precancer treatment: use of cell cycle analysis.
    Thomson PJ; Hamadah O; Goodson ML; Cragg N; Booth C
    Br J Oral Maxillofac Surg; 2008 Jul; 46(5):370-5. PubMed ID: 18282643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
    Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
    Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.